In future prospective studies, screening GFAP-Abs in patients with inflammatory PNS disease of unknown etiology, associated or not with CNS symptoms or meningitis, may be useful to better define the spectrum of GFAP-Abs-related disease phenotypes. This evidence concerns the gene GFAP and meningitis.